Figure 1 (Opfolda 01)
Opfolda Capsule
Product Images NDC 71904-300
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Opfolda (NDC 71904-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amicus Therapeutics Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Opfolda 02)
Figure 2 (Opfolda 03)
Figure 3 (Opfolda 04)
4 Count Bottle Label (Opfolda 05)
24 Count Bottle Label (Opfolda 06)
100 Count Bottle Label (Opfolda 07)
Each capsule of this medication contains 65 mg of migLUstat. It is recommended to store the medication in its original container or an equivalent, protecting it from light at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should not be used if the inner seal is missing or broken, and should be kept out of the reach of children. The recommended dosage should be followed as per the prescribing information. The medication is manufactured by Amicus Therapeutics US, LLC and the address is 3675 Market Street, Philadelphia, PA 19104. OPFOLDA and POMBILITI are trademarks of Amicus Therapeutics, Inc. The National Drug Code (NDC) for this medication is 71904-300-03. Please note that OPFOLDA is for use only with POMBILITI™ and fasting is required 2 hours before and 2 hours after taking OPFOLDA. The package contains 100 capsules and it is a prescription-only medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
